Today, patient groups representing millions of individuals with serious diseases and health conditions submitted an amicus curiae (friend of the court) brief urging the U.S. Court of Appeals for the ...
"FDA’s granting of these marketing order to 20 flavored products is a gift to the tobacco industry. The American Lung Association sees FDA’s authorization Zyn Citrus, Zyn Cool Mint, Zyn Chill and ...
Dr. Edward Garon explains the role of immunotherapy, PD-L1 and PD-1 in lung cancer. Dr. Edward Garon explains the role of a patient’s PD-L1 levels in lung cancer treatment decision making. Dr. Edward ...
Dr. Melissa Johnson discusses the past, present and future of treating KRAS-positive lung cancer. KRAS is an important biomarker in lung cancer. Dr. Sandip Patel discusses advances made in treating ...
ALK-positive lung cancer patient, Lisa, shares what she would tell a newly diagnosed ALK-lung cancer patient. Dr. Ross Camidge explains how a lung cancer patient knows if they have ALK-positive lung ...
Hear Daniel, husband of a lung cancer survivor, discuss the importance of comprehensive biomarker testing. EGFR-positive lung cancer patient, Ashley, shares what she would tell a newly diagnosed ...
Dr. Karen Kelly explains what a BRAF-V600E fusion is in lung cancer. Dr. Karen Kelly explains the importance of testing for BRAF-V600E fusions is in lung cancer. The videos above were produced in 2020 ...
Dr. Robert Doebele explains how NTRK gene fusions are treated. NTRK is an important biomarker that can impact lung what treatment options. Dr. Robert Doebele explains what an NTRK gene fusion is in ...